ARGX250117C250000
- 0.00
- 0.000.00%
argenx SE Newsroom
Argenx Cut to Sell at Deutsche Bank on Valuation
Deutsche Bank Initiates Argenx SE(ARGX.US) With Sell Rating
Here's How Much You Would Have Made Owning Argenx Stock In The Last 5 Years
European Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday Trading
H.C. Wainwright Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $717
JMP Securities Maintains Market Outperform on Argenx, Raises Price Target to $696
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $696 to $772
Argenx Se: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
Express News | Argenx SE : Wedbush Raises Target Price to $715 From $665
Express News | Argenx SE : Jefferies Raises Target Price to $772 From $750
argenx SE | 6-K: Report of foreign private issuer (related to financial reporting)
Immunology Company Argenx Estimates Higher Product Net Sales From Last Year
Argenx Preliminary 2024 Financial Results: $2.2B In Annual Product Sales, $737M In Q4 Revenue, And $3.4B In Cash Reserves
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Veru (VERU)
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
Piper Sandler Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $725
Piper Sandler Remains a Buy on Argenx Se (ARGX)
BofA Securities Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $761
Bank of America Securities Sticks to Their Buy Rating for Argenx Se (ARGX)
Argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference